Euclid Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-8,785
Closed -$312K 294
2016
Q2
$312K Buy
+8,785
New +$343K 0.01% 415
2016
Q1
Sell
-201,252
Closed -$8.65M 487
2015
Q4
$8.65M Buy
+201,252
New +$8.85M 0.26% 134
2015
Q3
Sell
-12,541
Closed -$626K 359
2015
Q2
$626K Buy
+12,541
New +$594K 0.01% 379
2015
Q1
Sell
-593,011
Closed -$28.6M 378
2014
Q4
$28.6M Buy
593,011
+46,651
+9% +$2.22M 0.27% 84
2014
Q3
$26.2M Buy
546,360
+47,034
+9% +$2.28M 0.19% 115
2014
Q2
$24.7M Sell
499,326
-130,825
-21% -$6.12M 0.17% 135
2014
Q1
$29.7M Buy
630,151
+175,178
+39% +$8.05M 0.22% 97
2013
Q4
$21.9M Sell
454,973
-17,548
-4% -$787K 0.18% 125
2013
Q3
$19.8M Buy
472,521
+120,493
+34% +$5.19M 0.2% 118
2013
Q2
$14.4M Buy
+352,028
New +$12.9M 0.18% 134

Other funds holding MET

Euclid Advisors's MET Position: Q3 2016 in Review

Euclid Advisors sold out of MetLife (MET) in Q3 2016, closing a stake of 8,785 shares — an estimated $312K sold.

Euclid Advisors first reported a position in MET in Q2 2013 and held it in 10 quarters. The position peaked at $29.7M in Q1 2014. 963 funds tracked by Wall St. Rank hold MET as of Q3 2016.

  • Euclid Advisors reported no remaining MetLife position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 8,785 MetLife shares in Q3 2016, an estimated $312K.
  • Euclid Advisors first reported a position in MetLife in Q2 2013 and held it in 10 quarters.
  • Euclid Advisors's MetLife position peaked at $29.7M in Q1 2014.
  • 963 funds tracked by Wall St. Rank held MetLife as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.